Your browser doesn't support javascript.
loading
Highlight selection of radiochemistry and radiopharmacy developments by editorial board.
Toyohara, Jun; Vugts, Danielle; Kiss, Oliver C; Todde, Sergio; Li, Xiang-Guo; Liu, Zhibo; Yang, Zhi; Gillings, Nic; Cazzola, Emiliano; Szymanski, Wiktor; Meulen, Nick van der; Reilly, Raymond; Taddei, Carlotta; Schirrmacher, Ralf; Li, Zijing; Lagebo, Yohannes Jorge; Bentaleb, Naoual; Souza Albernaz, Marta de; Lapi, Suzanne; Ramogida, Caterina; Mukherjee, Archana; Ajenjo, Javier; Deuther-Conrad, Winnie; Bourdeau, Cécile.
Affiliation
  • Toyohara J; Tokyo Metropolitan Institute for Geriatrics and Gerontology, Tokyo, Japan.
  • Vugts D; Amsterdam University Medical Center, Amsterdam, The Netherlands.
  • Kiss OC; Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany. o.kiss@hzdr.de.
  • Todde S; University of Milano-Bicoccia, Tecnomed Foundation, Monza, Italy.
  • Li XG; Turku PET Centre and Department of Chemistry, and InFLAMES Research Flagship Center, University of Turku, Turku, Finland.
  • Liu Z; Peking University, Beijing, China.
  • Yang Z; Peking University Cancer Hospital & Institute, Beijing, China.
  • Gillings N; Copenhagen University Rigshospitalet, Copenhagen, Denmark.
  • Cazzola E; Sacro Cuore Hospital, Verona, Italy.
  • Szymanski W; University of Groningen, Groningen, The Netherlands.
  • Meulen NV; Paul Scherrer Institute (PSI), Villigen, Switzerland.
  • Reilly R; University of Toronto, Toronto, Canada.
  • Taddei C; Life Molecular Imaging GmbH, Berlin, Germany.
  • Schirrmacher R; University of Alberta, Edmonton, Canada.
  • Li Z; Xiamen University, Xiamen, China.
  • Lagebo YJ; Addis Ababa University, Addis Ababa, Ethiopia.
  • Bentaleb N; National Center for Nuclear Energy, Science and Technology-CNESTEN, Rabat, Morocco.
  • Souza Albernaz M; University Hospital Clementino Fraga Filho, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
  • Lapi S; University of Alabama at Birmingham, Birmingham, USA.
  • Ramogida C; Simon Fraser University, Burnaby, Vancouver, Canada.
  • Mukherjee A; TRIUMF, Burnaby, Vancouver, Canada.
  • Ajenjo J; Bhabha Atomic Research Center and Homi Bhabha National Institute, Mumbai, India.
  • Deuther-Conrad W; Molecular Imaging Program at Stanford (MIPS), Dept of Radiology, School of Medicine, Stanford University, Stanford, CA), USA.
  • Bourdeau C; Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Leipzig, Germany.
EJNMMI Radiopharm Chem ; 9(1): 42, 2024 May 16.
Article in En | MEDLINE | ID: mdl-38753262
ABSTRACT

BACKGROUND:

The Editorial Board of EJNMMI Radiopharmacy and Chemistry releases a biannual highlight commentary to update the readership on trends in the field of radiopharmaceutical development. MAIN BODY This selection of highlights provides commentary on 24 different topics selected by each coauthoring Editorial Board member addressing a variety of aspects ranging from novel radiochemistry to first-in-human application of novel radiopharmaceuticals.

CONCLUSION:

Trends in radiochemistry and radiopharmacy are highlighted. Hot topics cover the entire scope of EJNMMI Radiopharmacy and Chemistry, demonstrating the progress in the research field in many aspects.
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: EJNMMI Radiopharm Chem Year: 2024 Document type: Article Affiliation country: Japan
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: EJNMMI Radiopharm Chem Year: 2024 Document type: Article Affiliation country: Japan